Media type: E-Article Title: P87.02 AcceleRET Lung: A Phase 3 Study of First-Line Pralsetinib in Patients with RET-Fusion+ Advanced/Metastatic NSCLC Contributor: Besse, B.; Felip, E.; Kim, E.S.; Clifford, C.; Louie-Gao, M.; Yagui-Beltran, A.; Popat, S. Published: Elsevier BV, 2021 Published in: Journal of Thoracic Oncology, 16 (2021) 3, Seite S684 Language: English DOI: 10.1016/j.jtho.2021.01.1257 ISSN: 1556-0864 Origination: Footnote: Access State: Open Access